Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 201 entries
Sorted by: Best Match Show Resources per page
Nanodrug particles and nanoformulations for drug delivery.

Advanced drug delivery reviews

Chan HK.
PMID: 21601602
Adv Drug Deliv Rev. 2011 May 30;63(6):405. doi: 10.1016/j.addr.2011.05.006. Epub 2011 May 14.

No abstract available.

Cite
Chan HK. Nanodrug particles and nanoformulations for drug delivery. Adv Drug Deliv Rev. 2011;63(6):405doi: 10.1016/j.addr.2011.05.006.
Chan, H. K. (2011). Nanodrug particles and nanoformulations for drug delivery. Advanced drug delivery reviews, 63(6), 405. https://doi.org/10.1016/j.addr.2011.05.006
Chan, Hak-Kim. "Nanodrug particles and nanoformulations for drug delivery." Advanced drug delivery reviews vol. 63,6 (2011): 405. doi: https://doi.org/10.1016/j.addr.2011.05.006
Chan HK. Nanodrug particles and nanoformulations for drug delivery. Adv Drug Deliv Rev. 2011 May 30;63(6):405. doi: 10.1016/j.addr.2011.05.006. Epub 2011 May 14. PMID: 21601602.
Copy Download .nbib Format: NLM
Systematic analysis of public domain compound potency data identifies selective molecular scaffolds across druggable target families.

Journal of medicinal chemistry

Hu Y, Wassermann AM, Lounkine E, Bajorath J.
PMID: 20000355
J Med Chem. 2010 Jan 28;53(2):752-8. doi: 10.1021/jm9014229.

Molecular scaffolds that yield target family-selective compounds are of high interest in pharmaceutical research. There continues to be considerable debate in the field as to whether chemotypes with a priori selectivity for given target families and/or targets exist and...

Cite
Hu Y, Wassermann AM, Lounkine E, et al. Systematic analysis of public domain compound potency data identifies selective molecular scaffolds across druggable target families. J Med Chem. 2010;53(2):752-8doi: 10.1021/jm9014229.
Hu, Y., Wassermann, A. M., Lounkine, E., & Bajorath, J. (2010). Systematic analysis of public domain compound potency data identifies selective molecular scaffolds across druggable target families. Journal of medicinal chemistry, 53(2), 752-8. https://doi.org/10.1021/jm9014229
Hu, Ye, et al. "Systematic analysis of public domain compound potency data identifies selective molecular scaffolds across druggable target families." Journal of medicinal chemistry vol. 53,2 (2010): 752-8. doi: https://doi.org/10.1021/jm9014229
Hu Y, Wassermann AM, Lounkine E, Bajorath J. Systematic analysis of public domain compound potency data identifies selective molecular scaffolds across druggable target families. J Med Chem. 2010 Jan 28;53(2):752-8. doi: 10.1021/jm9014229. PMID: 20000355.
Copy Download .nbib Format: NLM
Neglected diseases, neglected technologies, neglected patients?.

International journal of pharmaceutics

Florence AT.
PMID: 18191925
Int J Pharm. 2008 Feb 28;350(1):1-2. doi: 10.1016/j.ijpharm.2007.11.028. Epub 2007 Nov 22.

No abstract available.

Cite
Florence AT. Neglected diseases, neglected technologies, neglected patients?. Int J Pharm. 2007;350(1):1-2doi: 10.1016/j.ijpharm.2007.11.028.
Florence, A. T. (2008). Neglected diseases, neglected technologies, neglected patients?. International journal of pharmaceutics, 350(1), 1-2. https://doi.org/10.1016/j.ijpharm.2007.11.028
Florence, Alexander T. "Neglected diseases, neglected technologies, neglected patients?." International journal of pharmaceutics vol. 350,1 (2008): 1-2. doi: https://doi.org/10.1016/j.ijpharm.2007.11.028
Florence AT. Neglected diseases, neglected technologies, neglected patients?. Int J Pharm. 2008 Feb 28;350(1):1-2. doi: 10.1016/j.ijpharm.2007.11.028. Epub 2007 Nov 22. PMID: 18191925.
Copy Download .nbib Format: NLM
Theranostics for cancer therapy.

Current drug delivery

Palekar-Shanbhag P, Jog SV, Chogale MM, Gaikwad SS.
PMID: 23286214
Curr Drug Deliv. 2013 Jun;10(3):357-62. doi: 10.2174/1567201811310030013.

With over 10 million new cases per year worldwide, Cancer remains one of the most urgent health concerns and a difficult disease to treat. For an effective treatment, improved diagnostic and therapeutic techniques with minimal side-effects are required. Research...

Cite
Palekar-Shanbhag P, Jog SV, Chogale MM, et al. Theranostics for cancer therapy. Curr Drug Deliv. 2013;10(3):357-62doi: 10.2174/1567201811310030013.
Palekar-Shanbhag, P., Jog, S. V., Chogale, M. M., & Gaikwad, S. S. (2013). Theranostics for cancer therapy. Current drug delivery, 10(3), 357-62. https://doi.org/10.2174/1567201811310030013
Palekar-Shanbhag, Pradnya, et al. "Theranostics for cancer therapy." Current drug delivery vol. 10,3 (2013): 357-62. doi: https://doi.org/10.2174/1567201811310030013
Palekar-Shanbhag P, Jog SV, Chogale MM, Gaikwad SS. Theranostics for cancer therapy. Curr Drug Deliv. 2013 Jun;10(3):357-62. doi: 10.2174/1567201811310030013. PMID: 23286214.
Copy Download .nbib Format: NLM
Intelligent drug-delivery devices based on micro- and nano-technologies.

Therapeutic delivery

Chi AH, Clayton K, Burrow TJ, Lewis R, Luciano D, Alexis F, D'hers S, Elman NM.
PMID: 23323782
Ther Deliv. 2013 Jan;4(1):77-94. doi: 10.4155/tde.12.139.

This review focuses on the current drug-delivery modalities in R&D, as well as commercially available. Intelligent drug-delivery systems are described as novel technological innovations and clinical approaches to improve conventional treatments. These systems differ in methodology of therapeutic administration,...

Cite
Chi AH, Clayton K, Burrow TJ, et al. Intelligent drug-delivery devices based on micro- and nano-technologies. Ther Deliv. 2013;4(1):77-94doi: 10.4155/tde.12.139.
Chi, A. H., Clayton, K., Burrow, T. J., Lewis, R., Luciano, D., Alexis, F., D'hers, S., & Elman, N. M. (2013). Intelligent drug-delivery devices based on micro- and nano-technologies. Therapeutic delivery, 4(1), 77-94. https://doi.org/10.4155/tde.12.139
Chi, A H, et al. "Intelligent drug-delivery devices based on micro- and nano-technologies." Therapeutic delivery vol. 4,1 (2013): 77-94. doi: https://doi.org/10.4155/tde.12.139
Chi AH, Clayton K, Burrow TJ, Lewis R, Luciano D, Alexis F, D'hers S, Elman NM. Intelligent drug-delivery devices based on micro- and nano-technologies. Ther Deliv. 2013 Jan;4(1):77-94. doi: 10.4155/tde.12.139. PMID: 23323782.
Copy Download .nbib Format: NLM
Interfacing engineered nanoparticles with biological systems: anticipating adverse nano-bio interactions.

Small (Weinheim an der Bergstrasse, Germany)

Pelaz B, Charron G, Pfeiffer C, Zhao Y, de la Fuente JM, Liang XJ, Parak WJ, Del Pino P.
PMID: 23112130
Small. 2013 May 27;9(9):1573-84. doi: 10.1002/smll.201201229. Epub 2012 Oct 30.

The innovative use of engineered nanomaterials in medicine, be it in therapy or diagnosis, is growing dramatically. This is motivated by the current extraordinary control over the synthesis of complex nanomaterials with a variety of biological functions (e.g. contrast...

Cite
Pelaz B, Charron G, Pfeiffer C, et al. Interfacing engineered nanoparticles with biological systems: anticipating adverse nano-bio interactions. Small. 2012;9(9):1573-84doi: 10.1002/smll.201201229.
Pelaz, B., Charron, G., Pfeiffer, C., Zhao, Y., de la Fuente, J. M., Liang, X. J., Parak, W. J., & Del Pino, P. (2013). Interfacing engineered nanoparticles with biological systems: anticipating adverse nano-bio interactions. Small (Weinheim an der Bergstrasse, Germany), 9(9), 1573-84. https://doi.org/10.1002/smll.201201229
Pelaz, Beatriz, et al. "Interfacing engineered nanoparticles with biological systems: anticipating adverse nano-bio interactions." Small (Weinheim an der Bergstrasse, Germany) vol. 9,9 (2013): 1573-84. doi: https://doi.org/10.1002/smll.201201229
Pelaz B, Charron G, Pfeiffer C, Zhao Y, de la Fuente JM, Liang XJ, Parak WJ, Del Pino P. Interfacing engineered nanoparticles with biological systems: anticipating adverse nano-bio interactions. Small. 2013 May 27;9(9):1573-84. doi: 10.1002/smll.201201229. Epub 2012 Oct 30. PMID: 23112130.
Copy Download .nbib Format: NLM
Advanced drug delivery: perspectives and prospects. Preface.

Advanced drug delivery reviews

Lee VH, Ghandehari H.
PMID: 23228894
Adv Drug Deliv Rev. 2013 Jan;65(1):1-2. doi: 10.1016/j.addr.2012.12.001. Epub 2012 Dec 07.

No abstract available.

Cite
Lee VH, Ghandehari H. Advanced drug delivery: perspectives and prospects. Preface. Adv Drug Deliv Rev. 2012;65(1):1-2doi: 10.1016/j.addr.2012.12.001.
Lee, V. H., & Ghandehari, H. (2013). Advanced drug delivery: perspectives and prospects. Preface. Advanced drug delivery reviews, 65(1), 1-2. https://doi.org/10.1016/j.addr.2012.12.001
Lee, Vincent H L, and Ghandehari, Hamidreza. "Advanced drug delivery: perspectives and prospects. Preface." Advanced drug delivery reviews vol. 65,1 (2013): 1-2. doi: https://doi.org/10.1016/j.addr.2012.12.001
Lee VH, Ghandehari H. Advanced drug delivery: perspectives and prospects. Preface. Adv Drug Deliv Rev. 2013 Jan;65(1):1-2. doi: 10.1016/j.addr.2012.12.001. Epub 2012 Dec 07. PMID: 23228894.
Copy Download .nbib Format: NLM
Multifunctional nanomedicine platforms for cancer therapy.

Journal of nanoscience and nanotechnology

Zhang H.
PMID: 22852341
J Nanosci Nanotechnol. 2012 May;12(5):4012-8. doi: 10.1166/jnn.2012.6160.

Biocompatible nanomaterials have emerged as ideal platforms to develop multi-functionalization for achieving a compound effect using one system in which each component has a specially designed function. In this context, this article reviews multifunctional nanomedicine platforms for cancer therapy....

Cite
Zhang H. Multifunctional nanomedicine platforms for cancer therapy. J Nanosci Nanotechnol. 2012;12(5):4012-8doi: 10.1166/jnn.2012.6160.
Zhang, H. (2012). Multifunctional nanomedicine platforms for cancer therapy. Journal of nanoscience and nanotechnology, 12(5), 4012-8. https://doi.org/10.1166/jnn.2012.6160
Zhang, Haijun. "Multifunctional nanomedicine platforms for cancer therapy." Journal of nanoscience and nanotechnology vol. 12,5 (2012): 4012-8. doi: https://doi.org/10.1166/jnn.2012.6160
Zhang H. Multifunctional nanomedicine platforms for cancer therapy. J Nanosci Nanotechnol. 2012 May;12(5):4012-8. doi: 10.1166/jnn.2012.6160. PMID: 22852341.
Copy Download .nbib Format: NLM
Nanomedicine-based cancer targeting: a new weapon in an old war.

Nanomedicine (London, England)

McCarron PA, Faheem AM.
PMID: 20025458
Nanomedicine (Lond). 2010 Jan;5(1):3-5. doi: 10.2217/nnm.09.89.

No abstract available.

Cite
McCarron PA, Faheem AM. Nanomedicine-based cancer targeting: a new weapon in an old war. Nanomedicine (Lond). 2010;5(1):3-5doi: 10.2217/nnm.09.89.
McCarron, P. A., & Faheem, A. M. (2010). Nanomedicine-based cancer targeting: a new weapon in an old war. Nanomedicine (London, England), 5(1), 3-5. https://doi.org/10.2217/nnm.09.89
McCarron, Paul A, and Faheem, Ahmed Moustafa. "Nanomedicine-based cancer targeting: a new weapon in an old war." Nanomedicine (London, England) vol. 5,1 (2010): 3-5. doi: https://doi.org/10.2217/nnm.09.89
McCarron PA, Faheem AM. Nanomedicine-based cancer targeting: a new weapon in an old war. Nanomedicine (Lond). 2010 Jan;5(1):3-5. doi: 10.2217/nnm.09.89. PMID: 20025458.
Copy Download .nbib Format: NLM
Application of nanotechnology in cancers prevention, early detection and treatment.

Journal of cancer research and therapeutics

Patel SP, Patel PB, Parekh BB.
PMID: 25313725
J Cancer Res Ther. 2014 Jul-Sep;10(3):479-86. doi: 10.4103/0973-1482.138196.

Use of nanotechnology in medical science is a rapidly developing area. New opportunities of diagnosis, imaging and therapy have developed due to recent rapid advancement by nanotechnology. The most common areas to be affected are diagnostic, imaging and targeted...

Cite
Patel SP, Patel PB, Parekh BB. Application of nanotechnology in cancers prevention, early detection and treatment. J Cancer Res Ther. 2014;10(3):479-86doi: 10.4103/0973-1482.138196.
Patel, S. P., Patel, P. B., & Parekh, B. B. (2014). Application of nanotechnology in cancers prevention, early detection and treatment. Journal of cancer research and therapeutics, 10(3), 479-86. https://doi.org/10.4103/0973-1482.138196
Patel, Shraddha P, et al. "Application of nanotechnology in cancers prevention, early detection and treatment." Journal of cancer research and therapeutics vol. 10,3 (2014): 479-86. doi: https://doi.org/10.4103/0973-1482.138196
Patel SP, Patel PB, Parekh BB. Application of nanotechnology in cancers prevention, early detection and treatment. J Cancer Res Ther. 2014 Jul-Sep;10(3):479-86. doi: 10.4103/0973-1482.138196. PMID: 25313725.
Copy Download .nbib Format: NLM
Carbon nanotubes in medicine & biology - therapy and diagnostics.

Advanced drug delivery reviews

Ali-Boucetta H, Kostarelos K.
PMID: 24220279
Adv Drug Deliv Rev. 2013 Dec;65(15):1897-8. doi: 10.1016/j.addr.2013.11.002. Epub 2013 Nov 09.

No abstract available.

Cite
Ali-Boucetta H, Kostarelos K. Carbon nanotubes in medicine & biology - therapy and diagnostics. Adv Drug Deliv Rev. 2013;65(15):1897-8doi: 10.1016/j.addr.2013.11.002.
Ali-Boucetta, H., & Kostarelos, K. (2013). Carbon nanotubes in medicine & biology - therapy and diagnostics. Advanced drug delivery reviews, 65(15), 1897-8. https://doi.org/10.1016/j.addr.2013.11.002
Ali-Boucetta, Hanene, and Kostarelos, Kostas. "Carbon nanotubes in medicine & biology - therapy and diagnostics." Advanced drug delivery reviews vol. 65,15 (2013): 1897-8. doi: https://doi.org/10.1016/j.addr.2013.11.002
Ali-Boucetta H, Kostarelos K. Carbon nanotubes in medicine & biology - therapy and diagnostics. Adv Drug Deliv Rev. 2013 Dec;65(15):1897-8. doi: 10.1016/j.addr.2013.11.002. Epub 2013 Nov 09. PMID: 24220279.
Copy Download .nbib Format: NLM
This symposium was specially dedicated to the recognition of Sung Wan Kim (USA) and his vast contributions over his career. Preface.

Journal of controlled release : official journal of the Controlled Release Society

Park K, Bae YH, Grainger DW.
PMID: 21907741
J Control Release. 2011 Oct 30;155(2):113-4. doi: 10.1016/j.jconrel.2011.08.042. Epub 2011 Sep 02.

No abstract available.

Cite
Park K, Bae YH, Grainger DW. This symposium was specially dedicated to the recognition of Sung Wan Kim (USA) and his vast contributions over his career. Preface. J Control Release. 2011;155(2):113-4doi: 10.1016/j.jconrel.2011.08.042.
Park, K., Bae, Y. H., & Grainger, D. W. (2011). This symposium was specially dedicated to the recognition of Sung Wan Kim (USA) and his vast contributions over his career. Preface. Journal of controlled release : official journal of the Controlled Release Society, 155(2), 113-4. https://doi.org/10.1016/j.jconrel.2011.08.042
Park, Kinam, et al. "This symposium was specially dedicated to the recognition of Sung Wan Kim (USA) and his vast contributions over his career. Preface." Journal of controlled release : official journal of the Controlled Release Society vol. 155,2 (2011): 113-4. doi: https://doi.org/10.1016/j.jconrel.2011.08.042
Park K, Bae YH, Grainger DW. This symposium was specially dedicated to the recognition of Sung Wan Kim (USA) and his vast contributions over his career. Preface. J Control Release. 2011 Oct 30;155(2):113-4. doi: 10.1016/j.jconrel.2011.08.042. Epub 2011 Sep 02. PMID: 21907741.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 201 entries